Obetat Biopharma

Preclinical stage developing breakthrough therapy for Sever Obesity by increasing energy expenditure avoiding common side effects of the current drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jersey City, NJ, US
  • Currency USD
  • Founded November 2013
  • Employees 3
  • Incorporation Type Not Incorporated
  • Website obetat.com

Company Summary

OBETAT Biopharma is, a pre-clinical stage company developing an innovative new class of potent and safe anti-obesity peptide based drug meeting unmet needs of treating severe obesity and Preder-Willi Syndromes (orphan disease), is seeking strategic partners and fund to complete studies needed for IND application with US FDA.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free